Mature and immature extracranial teratomas in children: The UK Children's Cancer Study Group experience

Journal of Clinical Oncology

Volumn 26, Issue 21, 2008, Pages 3590-3597

  Mann, Jillian R ^a   Gray, Elizabeth S ^b   Thornton, Claire ^b   Raafat, Faro ^b   Robinson, Kathleen ^b   Collins, Gary S ^b   Gornall, Peter ^b   Huddart, Simon N ^b   Hale, Juliet P ^b   Oakhill, Anthony ^b  

^a BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; CISPLATIN; DACTINOMYCIN; EPIRUBICIN; ETOPOSIDE; IFOSFAMIDE; PACLITAXEL; VINCRISTINE;

ADOLESCENT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RELAPSE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CAUSE OF DEATH; CHILD; CHILD CARE; CLINICAL FEATURE; COCCYGEAL BONE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CYST FLUID; CYST RUPTURE; DISEASE SEVERITY; DRUG MEGADOSE; FEMALE; FOLLOW UP; GLIOSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MULTIPLE CYCLE TREATMENT; NEWBORN; OVARY TERATOMA; PARAPLEGIA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RISK FACTOR; SACROCOCCYX TERATOMA; TERATOMA; TESTIS TERATOMA; THORAX TERATOMA; TREATMENT OUTCOME; TUMOR BIOPSY; TUMOR LOCALIZATION; TUMOR RECURRENCE; UNITED KINGDOM; YOLK SAC TUMOR; DISEASE FREE SURVIVAL; PATHOLOGY; PRESCHOOL CHILD;

ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; GREAT BRITAIN; HUMANS; INFANT; MALE; NEOPLASM RECURRENCE, LOCAL; RISK FACTORS; TERATOMA;

EID: 49049083326     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.16.0622     Document Type: Article

References (17)

1. Gobel U, Calaminus G, Blohm M, et al: Extracranial non-testicular teratoma in childhood and adolescence: Introduction of a risk score for stratification of therapy. Klin Padiatr 209:228-234, 1997
2. Heifetz SA, Cushing B, Giller R, et al: Immature teratomas in children: Pathologic considerations. Am J Surg Pathol 22:1115-1124, 1998
3. Dehner LP: Gonadal and extragonadal germ cell neoplasms: Teratomas in childhood, in Finegold M, Benington JL (eds): Pathology of Neoplasia in Children and Adults. Philadelphia, PA, WB Saunders, 1986, pp 282-312
4. Gobel U, Calaminus G, Engert J, et al: Teratomas in infancy and childhood. Med Pediatr Oncol 31:8-15, 1998
5. Mann JR, Raafat F, Robinson K, et al: Mature and immature extracranial teratomas in children: The UK Children's Cancer Study Group's experience, in Jones WG, Appleyard I, Harnden P, et al (eds): Germ Cell Tumours IV. London, United Kingdom, John Libbey and Co Ltd, 1998, pp 237-246
6. Harms D, Zahn S, Gobel U, et al: Pathology and molecular biology of teratomas in childhood and adolescence. Klin Padiatr 218:296-302, 2006
7. De Backer A, Madern GC, Hakvoort-Cammel FGAJ, et al: Study of the factors associated with recurrence in children with sacrococcygeal teratoma, J Pediatr Surg 41:173-181, 2006
8. Rescorla FJ, Sawin RS, Coran AG, et al: Long-term outcome for infants and children with sacrococcygeal teratomas: A report from the Children's Cancer Group. J Pediatr Surg 33:171-176, 1998
9. Mann JR, Raafat F, Robinson K, et al: The United Kingdom Children's Cancer Study Group's Second Germ Cell Tumor Study: Carboplatin, etoposide and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity. J Clin Oncol 18:3809-3818, 2000
10. O'Connor DM, Norris HJ: The influence of grade on outcome of stage I immature (malignant) teratomas and the reproducibility of grading. Int J Gynae Pathol 13:283-289, 1994
11. Sauerbrei W, Schumacher M: A bootstrap resampling procedure for model building: Application to the Cox regression model. Stat Med 11:2093-2109, 1992
12. Tsuchida Y, Endo Y, Saito S, et al: Evaluation of alpha-fetoprotein in early infancy. J Pediatr Surg 13:155-156, 1978
13. Wu JT, Book L, Sudar K: Serum alpha-protein (AFP) levels in normal infant. Pediatr Res 15:50-52, 1981
14. Stevens M, Rey A, Bouvet N, et al: SIOP MMT 95: Intensified 6 drug versus standard (IVA) chemotherapy for high risk non metastatic rhabdomyosarcoma (RMS). J Clin Oncol 22:802s, 2004 (abstr 8515)
15. Calaminus G, Schmidt P, Schneider DT, et al: Factors influencing outcome of teratoma in infancy and childhood: Results of the German cooperative trials MAHO 92-98/MAKEI 96 and further stratification in MAKEI 2004. Abstracts of SIOP XXXVI, Oslo, September 2004, Ped Blood and Cancer 43:377-378, 2004
16. Huddart SN, Mann JR, Robinson K, et al: Sacrococcygeal teratomas: The UK Children's Study Group's experience I. Neonatal. Pediatr Surg Int 19:47-51, 2003
17. Derikx JPM, De Backer A, Van de Schoot L, et al: Long-term functional sequelae of sacrococcygeal teratoma: A national study from the Netherlands. J Pediatr Surg 42:1122-1126, 2007